Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Moleculin Biotech ROE 2016-2025 | MBRX

Current and historical return on equity (ROE) values for Moleculin Biotech (MBRX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Moleculin Biotech ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-06-30 $-0.03B $-0.01B -1800.00%
2025-03-31 $-0.02B $0.00B -296.77%
2024-12-31 $-0.02B $0.01B -166.04%
2024-09-30 $-0.03B $0.01B -164.38%
2024-06-30 $-0.03B $0.02B -99.01%
2024-03-31 $-0.03B $0.02B -87.80%
2023-12-31 $-0.03B $0.03B -81.63%
2023-09-30 $-0.03B $0.04B -62.43%
2023-06-30 $-0.03B $0.04B -61.22%
2023-03-31 $-0.03B $0.05B -55.86%
2022-12-31 $-0.03B $0.05B -48.19%
2022-09-30 $-0.03B $0.06B -37.68%
2022-06-30 $-0.02B $0.07B -28.09%
2022-03-31 $-0.02B $0.07B -22.64%
2021-12-31 $-0.02B $0.08B -17.96%
2021-09-30 $-0.02B $0.08B -21.98%
2021-06-30 $-0.01B $0.09B -27.18%
2021-03-31 $-0.02B $0.09B -58.39%
2020-12-31 $-0.02B $0.02B -107.94%
2020-09-30 $-0.02B $0.01B -118.03%
2020-06-30 $-0.02B $0.02B -115.15%
2020-03-31 $-0.01B $0.02B -55.56%
2019-12-31 $-0.01B $0.02B -72.22%
2019-09-30 $-0.01B $0.02B -68.57%
2019-06-30 $-0.01B $0.02B -60.61%
2019-03-31 $-0.01B $0.02B -91.80%
2018-12-31 $-0.01B $0.01B -71.64%
2018-09-30 $-0.01B $0.02B -68.57%
2018-06-30 $-0.01B $0.02B -70.27%
2018-03-31 $-0.01B $0.02B -57.89%
2017-12-31 $-0.01B $0.02B -50.70%
2017-09-30 $-0.01B $0.02B -40.58%
2017-06-30 $-0.01B $0.02B -30.30%
2017-03-31 $0.00B $0.02B -18.75%
2016-12-31 $0.00B $0.02B -25.53%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.018B $0.000B
Moleculin Biotech, Inc. is a preclinical and clinical-stage pharmaceutical company which focused on the development of anti-cancer drug candidates. The company's lead product candidate is Annamycin, a Phase II clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia. Moleculin Biotech, Inc. is based in Houston, TX.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $247.892B 18.08
Amgen (AMGN) United States $155.032B 13.20
Gilead Sciences (GILD) United States $141.353B 14.72
Vertex Pharmaceuticals (VRTX) United States $99.756B 25.72
Bristol Myers Squibb (BMY) United States $96.948B 7.08
GSK (GSK) United Kingdom $81.288B 9.46
CSL (CSLLY) Australia $67.780B 0.00
Regeneron Pharmaceuticals (REGN) United States $62.210B 15.14
Alnylam Pharmaceuticals (ALNY) United States $59.533B 0.00
Argenex SE (ARGX) Netherlands $43.327B 76.21
Insmed (INSM) United States $28.436B 0.00
BioNTech SE (BNTX) Germany $24.763B 0.00
Royalty Pharma (RPRX) United States $21.029B 8.21
Biogen (BIIB) United States $19.992B 8.52
Incyte (INCY) United States $16.567B 21.10
Genmab (GNMSF) Denmark $15.979B 14.15
Genmab (GMAB) Denmark $15.897B 14.49
Illumina (ILMN) United States $15.299B 23.93
Ascendis Pharma (ASND) Denmark $11.814B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.264B 15.90
Swedish Orphan Biovitrum (BIOVF) Sweden $10.947B 24.21
QIAGEN (QGEN) Netherlands $10.668B 20.45
Exelixis (EXEL) United States $10.367B 18.69
Moderna (MRNA) United States $9.766B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $9.150B 0.00
Exact Sciences (EXAS) United States $8.843B 0.00
Bio-Techne Corp (TECH) United States $8.813B 32.50
Halozyme Therapeutics (HALO) United States $8.560B 15.06
Roivant Sciences (ROIV) United Kingdom $8.188B 0.00
Guardant Health (GH) United States $7.919B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.548B 40.27
Revolution Medicines (RVMD) United States $7.111B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.795B 0.00
Anbio Biotechnology (NNNN) Germany $6.754B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Repligen (RGEN) United States $6.688B 72.93
Legend Biotech (LEGN) United States $6.380B 0.00
Avidity Biosciences (RNA) United States $6.152B 0.00
Axsome Therapeutics (AXSM) United States $6.081B 0.00
Abivax SA (ABVX) France $6.003B 0.00
Nuvalent (NUVL) United States $5.489B 0.00
Merus (MRUS) Netherlands $5.089B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.869B 0.00
Alkermes (ALKS) Ireland $4.829B 13.42
Zealand Pharma (ZLDPF) Denmark $4.688B 4.63
TG Therapeutics (TGTX) United States $4.533B 77.22
Cytokinetics (CYTK) United States $4.527B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.483B 41.52
Krystal Biotech (KRYS) United States $4.273B 30.01
ADMA Biologics Inc (ADMA) United States $4.116B 29.74
Telix Pharmaceuticals (TLX) Australia $4.095B 0.00
Vaxcyte (PCVX) United States $3.966B 0.00
PTC Therapeutics (PTCT) United States $3.954B 6.57
Jyong Biotech (MENS) Taiwan $3.893B 0.00
Arcellx (ACLX) United States $3.877B 0.00
Akero Therapeutics (AKRO) United States $3.855B 0.00
Ascentage Pharma Group - (AAPG) China $3.849B 0.00
Protagonist Therapeutics (PTGX) United States $3.822B 87.76
Mirum Pharmaceuticals (MIRM) United States $3.750B 0.00
Metsera (MTSR) United States $3.679B 0.00
Zai Lab (ZLAB) United States $3.639B 0.00
Apellis Pharmaceuticals (APLS) United States $3.564B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.560B 0.00
Scholar Rock Holding (SRRK) United States $3.314B 0.00
Ligand Pharmaceuticals (LGND) United States $3.118B 0.00
Kymera Therapeutics (KYMR) United States $3.021B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.013B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.997B 0.00
Viking Therapeutics (VKTX) United States $2.993B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.899B 0.00
Bavarian Nordic (BVNRY) Denmark $2.877B 13.98
Immunovant (IMVT) United States $2.646B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.609B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.497B 842.50
Tarsus Pharmaceuticals (TARS) United States $2.441B 0.00
Alvotech (ALVO) Luxembourg $2.421B 18.25
Liquidia Technologies (LQDA) United States $2.411B 0.00
Amicus Therapeutics (FOLD) United States $2.355B 0.00
Agios Pharmaceuticals (AGIO) United States $2.282B 0.00
Denali Therapeutics (DNLI) United States $2.281B 0.00
ImmunityBio (IBRX) United States $2.212B 0.00
IDEAYA Biosciences (IDYA) United States $2.191B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.189B 12.27
Recursion Pharmaceuticals (RXRX) United States $2.123B 0.00
Celcuity (CELC) United States $2.120B 0.00
Disc Medicine (IRON) United States $2.084B 0.00
Mesoblast (MESO) Australia $2.063B 0.00
Belite Bio (BLTE) United States $2.044B 0.00
CG Oncology (CGON) United States $2.019B 0.00
ANI Pharmaceuticals (ANIP) United States $1.994B 17.88
Adaptive Biotechnologies (ADPT) United States $1.975B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.877B 0.00
Vericel (VCEL) United States $1.811B 299.08
Sarepta Therapeutics (SRPT) United States $1.766B 0.00
Certara (CERT) United States $1.762B 32.26
Apogee Therapeutics (APGE) United States $1.742B 0.00
Beam Therapeutics (BEAM) United States $1.706B 0.00
Cidara Therapeutics (CDTX) United States $1.658B 0.00
Biohaven (BHVN) United States $1.650B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.645B 0.00
Twist Bioscience (TWST) United States $1.641B 0.00
WAVE Life Sciences (WVE) Singapore $1.604B 0.00
Travere Therapeutics (TVTX) United States $1.555B 0.00
Edgewise Therapeutics (EWTX) United States $1.522B 0.00
Viridian Therapeutics (VRDN) United States $1.516B 0.00
Celldex Therapeutics (CLDX) United States $1.501B 0.00
Cogent Biosciences (COGT) United States $1.408B 0.00
Vera Therapeutics (VERA) United States $1.405B 0.00
Janux Therapeutics (JANX) United States $1.403B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.401B 0.00
MannKind (MNKD) United States $1.387B 41.09
89BIO (ETNB) United States $1.385B 0.00
Precigen (PGEN) United States $1.368B 0.00
NovoCure (NVCR) Jersey $1.332B 0.00
AbCellera Biologics (ABCL) Canada $1.300B 0.00
Pharvaris (PHVS) Netherlands $1.243B 0.00
Novavax (NVAX) United States $1.231B 3.32
Intellia Therapeutics (NTLA) United States $1.226B 0.00
GRAIL (GRAL) United States $1.212B 0.00
CureVac (CVAC) Germany $1.207B 5.60
Dynavax Technologies (DVAX) United States $1.203B 51.30
Pacira BioSciences (PCRX) United States $1.174B 12.44
Arcus Biosciences (RCUS) United States $1.124B 0.00
Zymeworks (ZYME) United States $1.122B 0.00
Sionna Therapeutics (SION) United States $1.109B 0.00
Structure Therapeutics (GPCR) United States $1.094B 0.00
LENZ Therapeutics (LENZ) United States $1.066B 0.00
MiMedx (MDXG) United States $1.061B 23.90
Stoke Therapeutics (STOK) United States $1.058B 22.71
CorMedix Inc (CRMD) United States $1.056B 18.85
Spyre Therapeutics (SYRE) United States $1.035B 0.00
Nuvation Bio (NUVB) United States $1.010B 0.00
Mineralys Therapeutics (MLYS) United States $1.008B 0.00
Oric Pharmaceuticals (ORIC) United States $0.996B 0.00
Praxis Precision Medicines (PRAX) United States $0.987B 0.00
Trevi Therapeutics (TRVI) United States $0.974B 0.00
Pharming Group (PHAR) Netherlands $0.957B 0.00
NeoGenomics (NEO) United States $0.915B 0.00
Urogen Pharma (URGN) United States $0.904B 0.00
Upstream Bio (UPB) United States $0.900B 0.00
Geron (GERN) United States $0.900B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.883B 0.00
Iovance Biotherapeutics (IOVA) United States $0.876B 0.00
Pharming Group (PHGUF) Netherlands $0.872B 0.00
Immunome (IMNM) United States $0.866B 0.00
UniQure (QURE) Netherlands $0.864B 0.00
Fortrea Holdings (FTRE) United States $0.820B 14.56
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.816B 0.00
Anavex Life Sciences (AVXL) United States $0.812B 0.00
Sana Biotechnology (SANA) United States $0.801B 0.00
BGM Group (BGM) China $0.788B 0.00
Gyre Therapeutics (GYRE) United States $0.781B 162.20
Dianthus Therapeutics (DNTH) United States $0.780B 0.00
ArriVent BioPharma (AVBP) United States $0.779B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.779B 0.00
Niagen Bioscience (NAGE) United States $0.779B 75.11
Day One Biopharmaceuticals (DAWN) United States $0.777B 0.00
Tango Therapeutics (TNGX) United States $0.768B 0.00
Oculis Holding AG (OCS) Switzerland $0.756B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.749B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.731B 0.00
Nurix Therapeutics (NRIX) United States $0.730B 0.00
Vir Biotechnology (VIR) United States $0.727B 0.00
GH Research (GHRS) Ireland $0.709B 0.00
Zenas BioPharma (ZBIO) United States $0.704B 0.00
Arbutus Biopharma (ABUS) United States $0.700B 0.00
Tyra Biosciences (TYRA) United States $0.686B 0.00
Kura Oncology (KURA) United States $0.682B 0.00
Immatics (IMTX) Germany $0.656B 0.00
Bicara Therapeutics (BCAX) United States $0.656B 0.00
Castle Biosciences (CSTL) United States $0.646B 63.66
Sinovac Biotech (SVA) China $0.645B 0.00
Keros Therapeutics (KROS) United States $0.630B 50.06
Rezolute (RZLT) United States $0.626B 0.00
Palvella Therapeutics (PVLA) United States $0.624B 0.00
Maze Therapeutics (MAZE) United States $0.608B 0.00
Terns Pharmaceuticals (TERN) United States $0.603B 0.00
MeiraGTx Holdings (MGTX) United States $0.599B 0.00
Arvinas (ARVN) United States $0.593B 0.00
Verastem (VSTM) United States $0.572B 0.00
AnaptysBio (ANAB) United States $0.571B 0.00
Septerna (SEPN) United States $0.563B 0.00
Gossamer Bio (GOSS) United States $0.559B 0.00
Myriad Genetics (MYGN) United States $0.552B 0.00
Rapport Therapeutics (RAPP) United States $0.546B 0.00
Opthea (OPT) Australia $0.525B 0.00
Cytek Biosciences (CTKB) United States $0.520B 0.00
Alumis (ALMS) United States $0.512B 0.00
ATyr Pharma (ATYR) United States $0.507B 0.00
Inventiva S.A (IVA) France $0.500B 0.00
Tectonic Therapeutic (TECX) United States $0.497B 0.00
Kodiak Sciences (KOD) United States $0.493B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.485B 0.00
MBX Biosciences (MBX) United States $0.481B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.470B 0.00
Cullinan Therapeutics (CGEM) United States $0.468B 0.00
Eton Pharmaceuticals (ETON) United States $0.463B 0.00
Prime Medicine (PRME) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.461B 0.00
Emergent Biosolutions (EBS) United States $0.458B 3.75
Compass Therapeutics (CMPX) United States $0.454B 0.00
Erasca (ERAS) United States $0.448B 0.00
ITeos Therapeutics (ITOS) United States $0.448B 0.00
REGENXBIO (RGNX) United States $0.446B 0.00
Solid Biosciences (SLDB) United States $0.438B 0.00
PureTech Health (PRTC) United States $0.435B 0.00
Replimune (REPL) United States $0.432B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.418B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.413B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.411B 0.00
Kamada (KMDA) Israel $0.410B 20.97
Corvus Pharmaceuticals (CRVS) United States $0.410B 0.00
XOMA Royalty (XOMA) United States $0.407B 0.00
Aura Biosciences (AURA) United States $0.400B 0.00
Inhibrx Biosciences (INBX) United States $0.397B 0.00
Olema Pharmaceuticals (OLMA) United States $0.394B 0.00
Northwest Biotherapeutics (NWBO) United States $0.391B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.389B 0.00
Absci (ABSI) United States $0.381B 0.00
I-Mab (IMAB) United States $0.367B 0.00
Astria Therapeutics (ATXS) United States $0.367B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.362B 0.00
Fulcrum Therapeutics (FULC) United States $0.359B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.358B 0.00
Abeona Therapeutics (ABEO) United States $0.354B 7.50
CytomX Therapeutics (CTMX) United States $0.341B 3.70
Benitec Biopharma (BNTC) United States $0.338B 0.00
Candel Therapeutics (CADL) United States $0.324B 0.00
Amarin (AMRN) Ireland $0.320B 0.00
DiaMedica Therapeutics (DMAC) United States $0.309B 0.00
Foghorn Therapeutics (FHTX) United States $0.306B 0.00
Bright Minds Biosciences (DRUG) United States $0.305B 0.00
Ocugen (OCGN) United States $0.304B 0.00
Design Therapeutics (DSGN) United States $0.301B 0.00
ScPharmaceuticals (SCPH) United States $0.294B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.288B 12.97
Tvardi Therapeutics (TVRD) United States $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.286B 0.00
Neumora Therapeutics (NMRA) United States $0.285B 0.00
Lifecore Biomedical (LFCR) United States $0.282B 0.00
Neurogene (NGNE) United States $0.281B 0.00
Contineum Therapeutics (CTNM) United States $0.281B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.280B 0.00
Crescent Biopharma (CBIO) United States $0.279B 0.00
Cartesian Therapeutics (RNAC) United States $0.276B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.273B 0.00
DBV Technologies S.A (DBVT) France $0.260B 0.00
Jade Biosciences (JBIO) United States $0.259B 0.00
Allogene Therapeutics (ALLO) United States $0.257B 0.00
Puma Biotechnology (PBYI) United States $0.257B 5.20
Vor Biopharma (VOR) $0.253B 0.00
Sagimet Biosciences (SGMT) United States $0.253B 0.00
Adherex Technologies (FENC) United States $0.251B 0.00
Prima BioMed (IMMP) Australia $0.244B 0.00
Alector (ALEC) United States $0.243B 0.00
Humacyte (HUMA) United States $0.242B 0.00
Codexis (CDXS) United States $0.241B 0.00
Editas Medicine (EDIT) United States $0.240B 0.00
Alpha Teknova (TKNO) United States $0.238B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.233B 0.00
Annexon (ANNX) United States $0.232B 0.00
Cognition Therapeutics (CGTX) United States $0.225B 0.00
EnGene Holdings (ENGN) Canada $0.222B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.216B 0.00
Entrada Therapeutics (TRDA) United States $0.216B 0.00
Adocia (ADOCY) France $0.216B 0.00
Monopar Therapeutics (MNPR) United States $0.215B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
GENFIT S.A (GNFT) France $0.207B 0.00
SELLAS Life Sciences (SLS) United States $0.202B 0.00
Aardvark Therapeutics (AARD) United States $0.195B 0.00
Innate Pharma S.A (IPHA) France $0.194B 0.00
Rapt Therapeutics (RAPT) United States $0.193B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.190B 0.00
Voyager Therapeutics (VYGR) United States $0.190B 0.00
Instil Bio (TIL) United States $0.189B 0.00
Immuneering (IMRX) United States $0.188B 0.00
Caribou Biosciences (CRBU) United States $0.184B 0.00
C4 Therapeutics (CCCC) United States $0.184B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.182B 0.00
Tevogen Bio Holdings (TVGN) United States $0.181B 0.00
Tenaya Therapeutics (TNYA) United States $0.179B 0.00
Ventyx Biosciences (VTYX) United States $0.179B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.176B 0.00
BioAge Labs (BIOA) United States $0.170B 0.00
Elicio Therapeutics (ELTX) United States $0.170B 0.00
Nuvectis Pharma (NVCT) United States $0.169B 0.00
Actuate Therapeutics (ACTU) United States $0.167B 0.00
Seres Therapeutics (MCRB) United States $0.165B 0.00
Citius Oncology (CTOR) United States $0.164B 0.00
Black Diamond Therapeutics (BDTX) United States $0.163B 12.48
Sangamo Therapeutics (SGMO) United States $0.162B 0.00
Kyverna Therapeutics (KYTX) United States $0.160B 0.00
Nkarta (NKTX) United States $0.159B 0.00
Greenwich LifeSciences (GLSI) United States $0.159B 0.00
Climb Bio (CLYM) United States $0.155B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.154B 0.00
Molecular Partners AG (MOLN) Switzerland $0.151B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.150B 0.00
MaxCyte (MXCT) United States $0.149B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
Cellectis S.A (CLLS) France $0.148B 0.00
TuHURA Biosciences (HURA) United States $0.145B 0.00
Agenus (AGEN) United States $0.145B 0.00
Cardiff Oncology (CRDF) United States $0.144B 0.00
Zura Bio (ZURA) United States $0.140B 0.00
Forte Biosciences (FBRX) United States $0.139B 0.00
BioHarvest Sciences (BHST) Canada $0.138B 0.00
Genelux (GNLX) United States $0.137B 0.00
Cabaletta Bio (CABA) United States $0.137B 0.00
Alpha Cognition (ACOG) Canada $0.133B 0.00
Coherus Oncology (CHRS) United States $0.133B 0.00
Anika Therapeutics (ANIK) United States $0.132B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.131B 0.00
Compugen (CGEN) Israel $0.131B 0.00
Inovio Pharmaceuticals (INO) United States $0.131B 0.00
Fate Therapeutics (FATE) United States $0.129B 0.00
Scilex Holding (SCLX) United States $0.125B 0.00
Seer (SEER) United States $0.116B 0.00
Equillium (EQ) United States $0.114B 0.00
Alto Neuroscience (ANRO) United States $0.112B 0.00
Spero Therapeutics (SPRO) United States $0.111B 0.00
Biomea Fusion (BMEA) United States $0.111B 0.00
IO Biotech (IOBT) Denmark $0.111B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.110B 0.00
Coya Therapeutics (COYA) United States $0.110B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.107B 0.00
Skye Bioscience (SKYE) United States $0.107B 0.00
BioStem Technologies (BSEM) $0.107B 5.60
Oncolytics Biotech (ONCY) Canada $0.106B 0.00
TScan Therapeutics (TCRX) United States $0.106B 0.00
XBiotech (XBIT) United States $0.106B 0.00
Oncobiologics (OTLK) United States $0.106B 0.00
23andMe Holding (MEHCQ) United States $0.105B 0.00
Invivyd (IVVD) United States $0.105B 0.00
HilleVax (HLVX) United States $0.104B 0.00
Pliant Therapeutics (PLRX) United States $0.104B 0.00
Adagene (ADAG) China $0.103B 0.00
Connect Biopharma Holdings (CNTB) United States $0.099B 0.00
VistaGen Therapeutics (VTGN) United States $0.098B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Elutia (ELUT) United States $0.094B 0.00
Celularity (CELU) United States $0.091B 0.00
Ovid Therapeutics (OVID) United States $0.090B 0.00
Entera Bio (ENTX) Israel $0.090B 0.00
Nautilus Biotechnology (NAUT) United States $0.089B 0.00
CervoMed (CRVO) United States $0.087B 0.00
Atara Biotherapeutics (ATRA) United States $0.087B 0.00
Whitehawk Therapeutics (WHWK) United States $0.085B 0.00
OKYO Pharma (OKYO) $0.085B 0.00
Immunic (IMUX) United States $0.084B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.084B 0.00
Quince Therapeutics (QNCX) United States $0.084B 0.00
EXoZymes (EXOZ) United States $0.081B 0.00
Artiva Biotherapeutics (ARTV) United States $0.080B 0.00
Sutro Biopharma (STRO) United States $0.077B 0.00
BeyondSpring (BYSI) United States $0.073B 0.00
Applied Therapeutics (APLT) United States $0.073B 0.00
ZIVO Bioscience (ZIVO) United States $0.072B 0.00
MiNK Therapeutics (INKT) United States $0.072B 0.00
Opus Genetics (IRD) United States $0.072B 0.00
Repare Therapeutics (RPTX) Canada $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.070B 0.00
TELA Bio (TELA) United States $0.070B 0.00
Aligos Therapeutics (ALGS) United States $0.070B 0.00
Fortress Biotech (FBIO) United States $0.070B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
KALA BIO (KALA) United States $0.068B 0.00
InflaRx (IFRX) Germany $0.067B 0.00
MediciNova (MNOV) United States $0.066B 0.00
Quantum Biopharma (QNTM) Canada $0.065B 0.00
ALX Oncology Holdings (ALXO) United States $0.064B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.064B 0.00
Adverum Biotechnologies (ADVM) United States $0.064B 0.00
Cue Biopharma (CUE) United States $0.063B 0.00
BioXcel Therapeutics (BTAI) United States $0.063B 0.00
Adicet Bio (ACET) United States $0.063B 0.00
Adlai Nortye (ANL) Cayman Islands $0.062B 0.00
Werewolf Therapeutics (HOWL) United States $0.061B 0.00
PDS Biotechnology (PDSB) United States $0.060B 0.00
Precision BioSciences (DTIL) United States $0.059B 0.00
Earth Science Tech (ETST) United States $0.059B 0.00
Kalaris Therapeutics (KLRS) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.057B 0.00
ImageneBio (IMA) United States $0.055B 0.00
INmune Bio (INMB) United States $0.054B 0.00
Clene (CLNN) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.052B 0.00
X4 Pharmaceuticals (XFOR) United States $0.048B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
Jasper Therapeutics (JSPR) United States $0.047B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.046B 0.00
Annovis Bio (ANVS) United States $0.046B 0.00
Radiopharm Theranostics - (RADX) Australia $0.044B 0.00
Renovaro (RENB) United States $0.044B 0.00
Alterity Therapeutics - (ATHE) Australia $0.044B 0.00
Lantern Pharma (LTRN) United States $0.044B 0.00
Generation Bio (GBIO) United States $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Senti Biosciences (SNTI) United States $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.041B 0.00
PepGen (PEPG) United States $0.041B 0.00
CalciMedica (CALC) United States $0.041B 0.00
Rani Therapeutics Holdings (RANI) United States $0.040B 0.00
Mersana Therapeutics (MRSN) United States $0.038B 0.00
OnKure Therapeutics (OKUR) United States $0.038B 0.00
Pluri (PLUR) Israel $0.038B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.037B 0.00
Medicus Pharma (MDCX) United States $0.036B 0.00
Exicure (XCUR) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Estrella Immunopharma (ESLA) United States $0.035B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.034B 0.00
RenovoRx (RNXT) United States $0.034B 0.00
Dyadic (DYAI) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Tenax Therapeutics (TENX) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
Tharimmune (THAR) United States $0.026B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.026B 0.00
BioAtla (BCAB) United States $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Rein Therapeutics (RNTX) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
Rallybio (RLYB) United States $0.025B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.024B 0.00
Synaptogenix (TAOX) United States $0.024B 0.00
Allarity Therapeutics (ALLR) United States $0.023B 0.00
Cingulate (CING) United States $0.023B 0.00
Passage Bio (PASG) United States $0.022B 0.00
SAB Biotherapeutics (SABS) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Q32 Bio (QTTB) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Curis (CRIS) United States $0.020B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.020B 0.00
Abpro Holdings (ABP) United States $0.020B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.019B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.018B 0.00
Flag Ship Acquisition (ETHZ) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Chemomab Therapeutics (CMMB) Israel $0.016B 0.00
LakeShore Biopharma (LSB) China $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.016B 0.00
MetaVia (MTVA) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Imunon (IMNN) United States $0.015B 0.00
Intensity Therapeutics (INTS) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
HCW Biologics (HCWB) United States $0.013B 0.00
Soligenix (SNGX) United States $0.013B 0.00
Gelteq (GELS) Australia $0.013B 0.00
Longeveron (LGVN) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
Beyond Air (XAIR) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Femasys (FEMY) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
IN8bio (INAB) United States $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Aptevo Therapeutics (APVO) United States $0.006B 0.00
Psyence Biomedical (PBM) Canada $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00